Protocol Ledger

NCT05065216 · Phase II/III · RECRUITING

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Interventional Phase II/III clinical trial protocol NCT05065216 sponsored by DiaMedica Therapeutics in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-11-07 Enrollment: 728 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05065216
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)728 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05065216
Protocol FieldVerified Registry Value
NCT IdentifierNCT05065216
Consolidated Lead SponsorDiaMedica Therapeutics
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment728 participants (ESTIMATED)
Registered Start Date2021-11-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI